Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms

Protein kinase B (AKT) is a serine/threonine kinase that functions as an important downstream effector of phosphoinositide 3-kinase. We have recently shown that MK-2206 and triciribine, two highly selective AKT inhibitors increase the level of low density lipoprotein receptor (LDLR) mRNA which leads...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjune, Katrine, Wierød, Lene, Naderi, Soheil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583949/
https://www.ncbi.nlm.nih.gov/pubmed/31216345
http://dx.doi.org/10.1371/journal.pone.0218537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583949/
https://www.ncbi.nlm.nih.gov/pubmed/31216345
http://dx.doi.org/10.1371/journal.pone.0218537

Ejemplares similares